High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer - a randomised phase II-III trial of the EORTC Gastrointestinal Group

Author： Wils J.   Blijham G.H.   Wagener T.   De Greve J.   Jansen R.L.H.   Kok T.C.   Nortier J.W.R.   Bleiberg H.   Couvreur M.L.   Genicot B.   Baron B.   on behalf of the EORTC Gastrointestinal Group  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.3, 2003-02, pp. : 346-352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of 5-Fluorouracil with Methotrexate and Low-dose N-(phosphonacetyl)-l-aspartate in Patients with Advanced Colorectal Cancer. Results of a Phase II Study

By Kohne C.-H.   Harstrick A.   Hiddemann W.   Schoffski P.   Wilke H.   Bokemeyer C.   Dorken B.   Schmoll H.-J.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1896-1899

Elsevier

Access to resources Recommend Favorite

Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with -interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial

By Wagener D.J.T.   Wils J.A.   Kok T.C.   Planting A.   Couvreur M.L.   Baron B.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 648-653

Elsevier

Access to resources Recommend Favorite

Treatment of Advanced Colorectal Cancer with High-dose Intensity Folinic Acid and 5-Fluorouracil Plus Supportive Care

By Petrioli R.   Lorenzi M.   Aquino A.   Marsili S.   Frediani B.   Palazzuoli V.   Marzocca G.   Botta G.   Tani F.   De Martino A.   Testi W.   Setacci C.   Salvestrini F.   De Sando D.   Bovenga S.   Mariani L.   Mancini S.   Tanzini G.   Armenio S.   Marinello E.   Francini G.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2105-2108

Elsevier

Access to resources Recommend Favorite

A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501)

By Nakayama Norisuke   Koizumi Wasaburo   Tanabe Satoshi   Sasaki Tohru   Saigenji Katsunori  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 185-191

Springer Publishing Company

Access to resources Recommend Favorite

High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: A phase I trial

By Pfeiffer Per  

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 224-229

Informa Healthcare

Access to resources Recommend Favorite